Scientific Sessions 2024  /  Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy  /  Debate: PCI is the Optimal Modality for Management of Multivessel CAD and Severe Cardiomyopathy
Logo

American Heart Association

  99
  0

Final ID:

Debate: PCI is the Optimal Modality for Management of Multivessel CAD and Severe Cardiomyopathy

  • Mcentegart, Margaret  ( ColumbiaUniversityMedicalCenter , New York , New York , United States )
  • Perera, Divaka  ( St. Thomas' Hospital , London , United Kingdom )
    • Author Disclosures:
    Margaret McEntegart: DO have relevant financial relationships ; Consultant:Boston Scientific :Active (exists now) ; Consultant:Biosensors:Past (completed) ; Speaker:Medtronic:Past (completed) ; Speaker:Asahi:Past (completed) ; Consultant:Shockwave Medical:Active (exists now) | Divaka Perera: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Panel

Zwischenberger Brittany

Advances in Imaging for Viability Assessment to Aid in Treatment Planning

Woodard Pamela, Jacobs Jill, Ordovas Karen

You have to be authorized to contact abstract author. Please, Login
Not Available